Protein kinase D2 promotes the proliferation of glioma cells by regulating Golgi phosphoprotein 3

Cancer Letters

Volumn 355, Issue 1, 2014, Pages 121-129

  Zhou, Xiuping ^a   Xue, Pengfei ^a   Yang, Minglin ^a   Shi, Hengliang ^a   Lu, Dong ^a   Wang, Zhaohao ^a   Shi, Qiong ^a   Hu, Jinxia ^a   Xie, Shao ^a   Zhan, Wenjian ^a   Yu, Rutong ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

AKT; Glioblastoma; GOLPH3; PKD2; Proliferation

Indexed keywords

CELL ENZYME; GOLGI PHOSPHOPROTEIN 3; PROTEIN KINASE B; PROTEIN KINASE D2; TUMOR PROTEIN; UNCLASSIFIED DRUG; GOLPH3 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN KINASE;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR PROMOTION; UPREGULATION; BRAIN TUMOR; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GLIOMA; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MEMBRANE PROTEINS; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84907974666     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.09.008     Document Type: Article

References (40)

1. Legler J.M., et al. RESPONSE: Re: brain and other central nervous system cancers: recent trends in incidence and mortality. J. Natl Cancer Inst 1999, 91(23):2050A-22051.
2. Jones T.S., Holland E.C. Standard of care therapy for malignant glioma and its effect on tumor and stromal cells. Oncogene 2012, 31(16):1995-2006.
3. Rozengurt E. Protein kinase D signaling: multiple biological functions in health and disease. Physiology (Bethesda) 2011, 26(1):23-33.
4. Manning G., et al. The protein kinase complement of the human genome. Science 2002, 298(5600):1912-1934.
5. Rykx A., et al. Protein kinase D: a family affair. FEBS Lett 2003, 546(1):81-86.
6. Van Lint J., et al. Protein kinase D: an intracellular traffic regulator on the move. Trends Cell Biol 2002, 12(4):193-200.
7. Avkiran M., et al. Protein kinase d in the cardiovascular system: emerging roles in health and disease. Circ. Res 2008, 102(2):157-163.
8. Yin D.M., et al. Both the establishment and maintenance of neuronal polarity require the activity of protein kinase D in the Golgi apparatus. J. Neurosci 2008, 28(35):8832-8843.
9. Tan M., et al. Lysophosphatidylcholine activates a novel PKD2-mediated signaling pathway that controls monocyte migration. Arterioscler. Thromb. Vasc. Biol 2009, 29(9):1376-1382.
10. Shapiro B.A., et al. Angiotensin II-activated protein kinase D mediates acute aldosterone secretion. Mol. Cell. Endocrinol 2010, 317(1-2):99-105.
11. Azoitei N., et al. Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation. Neuro-Oncol 2011, 13(7):710-724.
12. Wei N., et al. Protein Kinase D as a Potential Chemotherapeutic Target for Colorectal Cancer. Mol. Cancer Ther 2014, 13(5):1130-1141.
13. Wille C., et al. Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases. Mol. Biol. Cell 2014, 25(3):324-336.
14. Hao Q., et al. Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells. Anticancer Res 2013, 33(2):393-399.
15. Zou Z.P., et al. PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-kappa B- and HDAC1-mediated expression and activation of uPA. J. Cell Sci 2012, 125(20):4800-4811.
16. Shabelnik M.Y., et al. Differential expression of PKD1 and PKD2 in gastric cancer and analysis of PKD1 and PKD2 function in the model system. Exp. Oncol 2011, 33(4):206-211.
17. Wu C.C., et al. GMx33: a novel family of trans-Golgi proteins identified by proteomics. Traffic 2000, 1(12):963-975.
18. Bell A.W., et al. Proteomics characterization of abundant Golgi membrane proteins. J. Biol. Chem 2001, 276(7):5152-5165.
19. Snyder C.M., et al. GMx33 associates with the trans-Golgi matrix in a dynamic manner and sorts within tubules exiting the Golgi. Mol. Biol. Cell 2006, 17(1):511-524.
20. McQuibban G.A., et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000, 289(5482):1202-1206.
21. Nelson A.R., et al. Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol 2000, 18(5):1135-1149.
22. Xu X., et al. Contributions of the MMP-2 collagen binding domain to gelatin cleavage. Substrate binding via the collagen binding domain is required for hydrolysis of gelatin but not short peptides. Matrix Biol 2004, 23(3):171-181.
23. Eskes R., et al. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol 2000, 20(3):929-935.
24. Scott K.L., et al. GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 2009, 459(7250):1085-1090.
25. Hu G.S., et al. High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma. Tumour Biol 2014, Epub ahead of print.
26. Li X.Y., et al. Expression of the Golgi phosphoprotein-3 gene in human gliomas: a pilot study. J. Neurooncol 2011, 105(2):159-163.
27. Xue Y., et al. GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma. Br. J. Cancer 2014, 110(9):2250-2260.
28. Ma Y.C., et al. High GOLPH3 expression is associated with a more aggressive behavior of epithelial ovarian carcinoma. Virchows Arch 2014, 464(4):443-452.
29. Zhou X.P., et al. GOLPH3 regulates the migration and invasion of glioma cells though RhoA. Biochem. Biophys. Res. Commun 2013, 433(3):338-344.
30. Zeng Z.L., et al. Overexpression of GOLPH3 Promotes Proliferation and Tumorigenicity in Breast Cancer via Suppression of the FOXO1 Transcription Factor. Clin. Cancer Res 2012, 18(15):4059-4069.
31. Isaji T., et al. An oncogenic protein Golgi phosphoprotein 3 up-regulates cell migration via sialylation. J. Biol. Chem 2014, 289(30):20694-20705.
32. Zhang X., et al. GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro. Mol. Carcinog 2014, Epub ahead of print.
33. Hausser A., et al. Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase III beta at the Golgi complex. Nat. Cell Biol 2005, 7(9):880-886.
34. Wood C.S., et al. PtdIns4P recognition by Vps74/GOLPH3 links PtdIns 4-kinase signaling to retrograde Golgi trafficking. J. Cell Biol 2009, 187(7):967-975.
35. Dippold H.C., et al. GOLPH3 Bridges Phosphatidylinositol-4-Phosphate and Actomyosin to Stretch and Shape the Golgi to Promote Budding. Cell 2009, 139(2):337-351.
36. Liljedahl M., et al. Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network. Cell 2001, 104(3):409-420.
37. Godi A., et al. ARF mediates recruitment of PtdIns-4-OH kinase-beta and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex. Nat. Cell Biol 1999, 1(5):280-287.
38. Scott K.L., Chin L. Signaling from the Golgi: mechanisms and models for Golgi phosphoprotein 3-mediated oncogenesis. Clin. Cancer Res 2010, 16(8):2229-2234.
39. Zhang J.Q., et al. RCP is a human breast cancer-promoting gene with Ras-activating function. J. Clin. Invest 2009, 119(8):2171-2183.
40. Hales C.M., et al. Identification and characterization of a family of Rab11-interacting proteins. J. Biol. Chem 2001, 276(42):39067-39075.